Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Journal of Neuroimmunology
|
May 1, 1994
The beta 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats
D H Kim, S Muthyala, B Soliven, et al.
Muscle & Nerve
|
October 1, 1987
Sympathetic skin response in diabetic neuropathy
B Soliven, R Maselli, J Jaspan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Phase I study of suramin administered by intermittent infusion without adaptive control to cancer patients: update of two expanded dose levels near the maximally tolerated dose
K Kobayashi, E E Vokes, N J Vogelzang, et al.
Glia
|
September 19, 2007
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells
C G Jung, H J Kim, V E Miron, et al.
Muscle & Nerve
|
January 1, 1997
Evaluation of neuropathy in patients on suramin treatment
B Soliven, U K Dhand, K Kobayashi, et al.
The Journal of Experimental Medicine
|
September 6, 2001
Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice
B Salomon, L Rhee, H Bour-Jordan, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Journal of Neuroimmunology
|
May 1, 1994
The beta 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats
D H Kim, S Muthyala, B Soliven, et al.
Muscle & Nerve
|
October 1, 1987
Sympathetic skin response in diabetic neuropathy
B Soliven, R Maselli, J Jaspan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Phase I study of suramin administered by intermittent infusion without adaptive control to cancer patients: update of two expanded dose levels near the maximally tolerated dose
K Kobayashi, E E Vokes, N J Vogelzang, et al.
Glia
|
September 19, 2007
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells
C G Jung, H J Kim, V E Miron, et al.
Muscle & Nerve
|
January 1, 1997
Evaluation of neuropathy in patients on suramin treatment
B Soliven, U K Dhand, K Kobayashi, et al.
The Journal of Experimental Medicine
|
September 6, 2001
Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice
B Salomon, L Rhee, H Bour-Jordan, et al.
Page
of 4